Daoyuan Y. Wu
Zhengzhou 450008, China Henan Key Laboratory Of Tumor Pathology And AI Based Diagnostic Medicine, Zhengzhou 450008
Zhengzhou, 450008, China
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
Integrated microbiome-metabolome profiling unveils a predictive signature for early recurrence in hepatocellular carcinoma.
Journal: Frontiers in microbiology
Published: June 24, 2025
A consistency comparison between next-generation sequencing and the FISH method for gene rearrangement detection in B-cell lymphomas
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 12, 2024
The prevalence of PD-L1 expression in patients with advanced oesophageal cancer: the EXCEED observational study.
Journal: Journal of clinical pathology
Published: June 28, 2024
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial.
Journal: Cancer communications (London, England)
Published: January 22, 2024
Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: December 08, 2022
Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer.
Journal: Frontiers in oncology
Published: May 25, 2022
NREP is a Diagnostic and Prognostic Biomarker, and Promotes Gastric Cancer Cell Proliferation and Angiogenesis.
Journal: Biochemical genetics
Published: November 03, 2021
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: August 22, 2021
Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance.
Journal: Frontiers in pharmacology
Published: July 27, 2021
Clinicopathological features and molecular genetics of Burkitt-like lymphoma with 11q aberration
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: June 03, 2021
Last Updated: 09/26/2026